propranolol has been researched along with Cystic Angiomatosis Of Bone, Diffuse in 3 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gorham-Stout syndrome is a rare disorder characterized by progressive osteolysis that leads to the disappearance of bone." | 1.39 | Gorham-Stout syndrome affecting the temporal bone with cerebrospinal fluid leakage. ( Kitamuara, M; Maekawa, T; Miyazaki, O; Morimoto, N; Morota, N; Nakazawa, A; Nishina, S; Ogiwara, H, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morimoto, N | 1 |
| Ogiwara, H | 1 |
| Miyazaki, O | 1 |
| Kitamuara, M | 1 |
| Nishina, S | 1 |
| Nakazawa, A | 1 |
| Maekawa, T | 1 |
| Morota, N | 1 |
| Nir, V | 1 |
| Guralnik, L | 1 |
| Livnat, G | 1 |
| Bar-Yoseph, R | 1 |
| Hakim, F | 1 |
| Ilivitzki, A | 1 |
| Bentur, L | 1 |
| Baud, J | 1 |
| Lomri, A | 1 |
| Graber, D | 1 |
| Bikfalvi, A | 1 |
3 other studies available for propranolol and Cystic Angiomatosis Of Bone, Diffuse
| Article | Year |
|---|---|
Gorham-Stout syndrome affecting the temporal bone with cerebrospinal fluid leakage.
Topics: Cerebrospinal Fluid Rhinorrhea; Child; Combined Modality Therapy; Female; Follow-Up Studies; Humans; | 2013 |
Propranolol as a treatment option in Gorham-Stout syndrome: a case report.
Topics: Adolescent; Female; Humans; Osteolysis, Essential; Propranolol | 2014 |
The therapeutic response in Gorham's syndrome to the beta-blocking agent propranolol is correlated to VEGF-A, but not to VEGF-C or FLT1 expression.
Topics: Adolescent; Adrenergic beta-Antagonists; Female; Humans; Lymphangiogenesis; Neovascularization, Path | 2015 |